WEI-WU HE, Ph.D. 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-23 5:15 pm Purchase | 2021-11-18 | 13D | CASI PHARMACEUTICALS INC CASI | WEI-WU HE, Ph.D. | 2,598,199 17.470% | 438,000 (+20.28%) | Filing |